DNA repair inhibitors: Where do we go from here?

DNA Repair

Volumn 10, Issue 11, 2011, Pages 1183-1185

  Kelley, Mark R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA REPAIR INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; TUMOR MARKER; UNCLASSIFIED DRUG;

DNA REPAIR; GENE EXPRESSION; HUMAN; NOTE; PRIORITY JOURNAL;

DNA REPAIR; ENZYME INHIBITORS; HUMANS; NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; SIGNAL TRANSDUCTION;

EID: 80054750785     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2011.09.003     Document Type: Note

References (12)

1. Maxmen A. Beyond PARP inhibitors: agents in pipelines target DNA repair mechanisms. J. Natl. Cancer Inst. 2010, 102:1110-1111.
2. Kelley M. Future directions with DNA repair inhibitors: a roadmap for disruptive approaches to cancer therapy. DNA Repair in Cancer Therapy: Molecular Targets and Clinical Applications 2012, 301-309. Academic Press/Elsevier. M. Kelley (Ed.).
3. Aziz K., Nowsheen S., Georgakilas A.G. Nanotechnology in cancer therapy: targeting the inhibition of key DNA repair pathways. Curr. Mol. Med. 2010, 10:626-639.
4. Rowe B.P., Glazer P.M. Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms. Breast Cancer Res. 2010, 12:203.
5. Willers H., Pfaffle H.N., Zou L. Targeting homologous recombination repair in cancer. DNA Repair in Cancer Therapy: Molecular Targets and Clinical Applications 2012, 119-151. Academic Press/Elsevier. M.R. Kelley (Ed.).
6. Shuck S.C., Short E.A., Turchi J.J. Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology. Cell Res. 2008, 18:64-72.
7. Helleday T., Petermann E., Lundin C., Hodgson B., Sharma R.A. DNA repair pathways as targets for cancer therapy. Nat. Rev. 2008, 8:193-204.
8. Perry C., Sultana R., Madhusudan S. Personalized cancer medicine: DNA repair alterations is a promising predictive marker in cancer. DNA Repair in Cancer Therapy: Molecular Targets and Clinical Applications 2012, 257-275. Academic Press/Elsevier. M.R. Kelley (Ed.).
9. de Bono J.S., Ashworth A. Translating cancer research into targeted therapeutics. Nature 2010, 467:543-549.
10. Abbotts R., Madhusudan S. Human AP endonuclease 1 (APE1): from mechanistic insights to druggable target in cancer. Cancer Treat. Rev. 2010, 36:425-435.
11. Gullotta F., De Marinis E., Ascenzi P., di Masi A. Targeting the DNA double strand breaks repair for cancer therapy. Curr. Med. Chem. 2010, 17:2017-2048.
12. Plummer R. Perspective on the pipeline of drugs being developed with modulation of DNA damage as a target. Clin. Cancer Res. 2010, 16:4527-4531.